Exhibit 107.1

 

Calculation of Filing Fee Table

 

Form S-3

(Form Type)

 

Augmedix, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

   Security
Type
  Security
Class Title
  Fee
Calculation or
Carry
Forward Rule
  Amount
Registered(1)
   Proposed
Maximum
Offering
Price Per
Unit(2)
   Maximum
Aggregate
Offering
Price(2)
   Fee Rate   Amount of
Registration
Fee(3)
   Carry
Forward
Form
Type
   Carry
Forward
File
Number
   Carry
Forward
Initial
effective
date
   Filing Fee
Previously
Paid In
Connection
with Unsold
Securities to
be Carried
Forward
 
Newly Registered Securities 
Fees to Be Paid  Equity  Common Stock, $0.0001 par value per share  Rule 457(c)   9,375,342   $3.32   $31,126,135.44    $110.20 per $1,000,000   $3,430.10                               
Fees Previously Paid  N/A  N/A  N/A   N/A    N/A    N/A         N/A                     
Carry Forward Securities 
Carry Forward Securities  N/A  N/A  N/A   N/A         N/A              N/A    N/A    N/A    N/A 
   Total Offering Amounts        $31,126,135.44        $3,430.10                     
   Total Fees Previously Paid                   -                     
   Total Fee Offsets                   -                     
   Net Fee Due                  $3,430.10                     

 

(1)Represents shares offered by the selling stockholders identified in this prospectus. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares being registered hereunder include such indeterminate number of shares of common stock as may be issuable with respect to the shares being registered hereunder as a result of any stock dividend, stock split, recapitalization or other similar transaction.
(2)Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) under the Securities Act.
(3)Calculated pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based upon the average of the high and low sales prices of the Common Stock as reported on the Nasdaq Capital Market on May 15, 2023.